Norbrook launches a new respiratory injectable for beef cattle

Beef farmers will have an alternative safeguard to control bacterial diseases within their cowherds with Tulieve, a genetic alternative from the veterinary pharmaceutical company, Norbrook.

A black and white-faced feeder steer stands in its pen.

Beef farmers will have an economic safeguard to control bacterial diseases within their cowherds with Tulieve, a genetic alternative from the veterinary pharmaceutical company, Norbrook.

The long-lasting antibiotic injectable, given in a single shot, has proved effective against several bacterial pathogens, including Bovine Respiratory Disease, Pasteurella, Infectious Bovine Keratoconjunctivitis, and foot rot. The injectable comes in 100 milliliter to 1-liter plastic bottle sizes, including plastic hanger bottles, which makes the product manageable in a farming environment.

"It's the only generic tulathromycin available in plastic bottles, making it easier for veterinarians and producers to handle while reducing the risk of product loss due to breakage," says Eric Moore, veterinarian and director of technical services for Norbrook.

Producers can administer Tulieve in low-volume doses to beef cattle and swine. In addition, the antibiotic has a short 18-day withdrawal time for beef and a five-day withdrawal for swine, giving veterinarians and producers more flexibility and options when managing sick animals.

"That's what makes this class of antibiotics so effective against a broad spectrum of diseases, especially respiratory diseases in cattle and swine," Moore says.

Cattle producers, veterinarians, and industry representatives attending the NCBA Convention in New Orleans, Feb. 1-3, will have the opportunity to learn more about Tulieve at the Norbrook exhibit.

Was this page helpful?

Related Articles